Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 28,647

Sort by:

Gastroparesis (Gastrointestinal) - Drugs in Development, 2021

US$ 2,000.00

Gastroparesis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Gastroparesis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Gastroparesis pipeline landscape. The re...

April 2021 40 pages

Gaucher Disease Type I (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease Type I (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Gaucher Disease Type I (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Gaucher Disease Type...

April 2021 40 pages

Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Gaucher Disease Type II (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Gaucher Disease Ty...

April 2021 30 pages

Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Gaucher Disease Type III (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Gaucher Disease...

April 2021 35 pages

Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) - Drugs in Development, 2021

US$ 3,000.00

Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) - Drugs in Development, 2021 SUMMARY Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) - Drugs in Development, 2021 provid...

April 2021 35 pages

General Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

General Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 SUMMARY General Anesthetic Effect (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Gene...

April 2021 40 pages

Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021

US$ 2,000.00

Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 SUMMARY Generalized Anxiety Disorder (GAD) (Central Nervous System) - Drugs in Development, 2021 provides an ov...

April 2021 35 pages

Genital Warts (Condylomata Acuminata) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Genital Warts (Condylomata Acuminata) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Genital Warts (Condylomata Acuminata) (Infectious Disease) - Drugs in Development, 2021 provides an over...

April 2021 55 pages

Genito Urinary System And Sex Hormones (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021

US$ 2,000.00

Genito Urinary System And Sex Hormones (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 SUMMARY Genito Urinary System And Sex Hormones (Genito Urinary System And Sex Hormones) - D...

April 2021 45 pages

Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021

US$ 2,000.00

Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021 SUMMARY Geographic Atrophy (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Geographic Atrophy pipeline landscap...

April 2021 80 pages

Germ Cell Tumors (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Germ Cell Tumors (Oncology) - Drugs in Development, 2021 SUMMARY Germ Cell Tumors (Oncology) - Drugs in Development, 2021 provides an overview of the Germ Cell Tumors pipeline landscape. The report pr...

April 2021 35 pages

Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) (Cardiovascular) - Drugs in Development, 2021

US$ 2,000.00

Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) (Cardiovascular) - Drugs in Development, 2021 SUMMARY Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disea...

April 2021 30 pages

Globohexaosylceramide (Globo H) - Drugs in Development, 2021

US$ 3,000.00

Globohexaosylceramide (Globo H) - Drugs in Development, 2021 SUMMARY Globohexaosylceramide (Globo H) - Drugs in Development, 2021 provides in depth analysis on Globohexaosylceramide (Globo H) targeted...

April 2021 30 pages

Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021

US$ 3,500.00

Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 SUMMARY Glucagon Like Peptide 1 Receptor (GLP1R) - Drugs in Development, 2021 provides in depth analysis on Glucagon Like Peptide...

April 2021 270 pages

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021

US$ 3,500.00

Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1 or NR3C1) - Drugs in Development, 2021 SUMMARY Glucocorticoid Receptor (GR or Nuclear Receptor Subfamily 3 Group C Member 1...

April 2021 220 pages

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) - Drugs in Development, 2021

US$ 3,000.00

Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1.3.9) - Drugs in Development, 2021 SUMMARY Glucose 6 Phosphatase (G6Pase or Glucose 6 Phosphatase Alpha or G6PC or EC 3.1....

April 2021 30 pages

Glutamate Ionotropic Receptor AMPA Type Subunit (AMPA Receptor or GRIA) - Drugs in Development, 2021

US$ 3,000.00

Glutamate Ionotropic Receptor AMPA Type Subunit (AMPA Receptor or GRIA) - Drugs in Development, 2021 SUMMARY Glutamate Ionotropic Receptor AMPA Type Subunit (AMPA Receptor or GRIA) - Drugs in Developm...

April 2021 55 pages

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021

US$ 3,000.00

Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021 SUMMARY Glutamate Ionotropic Receptor NMDA Type Subunit (NMDAR or GRIN) - Drugs in Development, 2021 provid...

April 2021 160 pages

Glutaminase (Glutamine Aminohydrolase or EC 3.5.1.2) - Drugs in Development, 2021

US$ 3,000.00

Glutaminase (Glutamine Aminohydrolase or EC 3.5.1.2) - Drugs in Development, 2021 SUMMARY Glutaminase (Glutamine Aminohydrolase or EC 3.5.1.2) - Drugs in Development, 2021 provides in depth analysis o...

April 2021 35 pages

Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) - Drugs in Development, 2021

US$ 3,000.00

Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cysteine S Nitrosylase GAPDH or GAPDH or EC 1.2.1.12) - Drugs in Development, 2021 SUMMARY Glyceraldehyde 3 Phosphate Dehydrogenase (Peptidyl Cystein...

April 2021 30 pages

Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Glycogen Storage Disease 1A (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the Glycogen S...

April 2021 35 pages

Glycogen Storage Disorders (GSD) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Glycogen Storage Disorders (GSD) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY Glycogen Storage Disorders (GSD) (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the...

April 2021 35 pages

Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in Development, 2021

US$ 3,000.00

Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in Development, 2021 SUMMARY Glycogen Synthase Kinase 3 (GSK3 or EC 2.7.11.26) - Drugs in Development, 2021 provides in depth analysis on Glyc...

April 2021 35 pages

Glycoprotein 140 (gp140) - Drugs in Development, 2021

US$ 3,000.00

Glycoprotein 140 (gp140) - Drugs in Development, 2021 SUMMARY Glycoprotein 140 (gp140) - Drugs in Development, 2021 provides in depth analysis on Glycoprotein 140 (gp140) targeted pipeline therapeutic...

April 2021 35 pages

GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Development, 2021 SUMMARY GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency) (Genetic Disorders) - Drugs in Develo...

April 2021 35 pages

Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Development, 2021

US$ 3,000.00

Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Development, 2021 SUMMARY Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Development, 2021 provides in depth analysis on Gonadotr...

April 2021 75 pages

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021

US$ 3,000.00

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021 SUMMARY GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) - Drugs in Development, 2021 provides in depth an...

April 2021 30 pages

Gram-Negative Bacterial Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,500.00

Gram-Negative Bacterial Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Gram-Negative Bacterial Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview o...

April 2021 220 pages

Gram-Positive Bacterial Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Gram-Positive Bacterial Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Gram-Positive Bacterial Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview o...

April 2021 120 pages

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) - Drugs in Development, 2021

US$ 3,000.00

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) - Drugs in Development, 2021 SUMMARY Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) - Drugs in Develo...

April 2021 105 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Drugs in Development, 2021

US$ 3,000.00

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Drugs in Development, 2021 SUMMARY Granulocyte Macrophage Colony Stimulating Factor Receptor Subun...

April 2021 45 pages

Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021

US$ 2,000.00

Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021 SUMMARY Growth Hormone Deficiency (Metabolic Disorders) - Drugs in Development, 2021 provides an overview of the Growth Hor...

April 2021 65 pages

Growth Hormone Receptor (Somatotropin Receptor or GHR) - Drugs in Development, 2021

US$ 3,000.00

Growth Hormone Receptor (Somatotropin Receptor or GHR) - Drugs in Development, 2021 SUMMARY Growth Hormone Receptor (Somatotropin Receptor or GHR) - Drugs in Development, 2021 provides in depth analys...

April 2021 75 pages

Growth/Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) - Drugs in Development, 2021

US$ 3,000.00

Growth/Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) - Drugs in Dev...

April 2021 35 pages

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021

US$ 3,000.00

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 SUMMARY GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Drugs in Development, 2021 provid...

April 2021 130 pages

Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Development, 2021

US$ 3,000.00

Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Development, 2021 SUMMARY Guanine Nucleotide Exchange C9orf72 (C9orf72) - Drugs in Development, 2021 provides in depth analysis on Guanine Nucl...

April 2021 35 pages

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) - Drugs in Development, 2021

US$ 3,000.00

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) - Drugs in Development, 2021 SUMMARY Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizi...

April 2021 30 pages

Gynecological Cancer (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Gynecological Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Gynecological Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Gynecological Cancer pipeline landscape. T...

April 2021 40 pages

Haemophilus influenzae Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Haemophilus influenzae Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Haemophilus influenzae Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of...

April 2021 35 pages

Hantavirus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Hantavirus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Hantavirus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Hantavirus Infection...

April 2021 35 pages

Head And Neck Carcinoma (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Head And Neck Carcinoma (Oncology) - Drugs in Development, 2021 SUMMARY Head And Neck Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Head And Neck Carcinoma pipeline lan...

April 2021 35 pages

Hearing Disorders (Ear Nose Throat Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hearing Disorders (Ear Nose Throat Disorders) - Drugs in Development, 2021 SUMMARY Hearing Disorders (Ear Nose Throat Disorders) - Drugs in Development, 2021 provides an overview of the Hearing Disord...

April 2021 115 pages

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) - Drugs in Development, 2021

US$ 3,000.00

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) - Drugs in Development, 2021 SUMMARY Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) - Drugs in Developm...

April 2021 35 pages

Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021

US$ 3,000.00

Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 70 (HSP70) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 70 (HSP70) targeted pipel...

April 2021 45 pages

Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021

US$ 3,000.00

Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 SUMMARY Heat Shock Protein 90 (HSP90) - Drugs in Development, 2021 provides in depth analysis on Heat Shock Protein 90 (HSP90) targeted pipel...

April 2021 80 pages

Helicobacter Pylori Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Helicobacter Pylori Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Helicobacter Pylori Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the He...

April 2021 60 pages

Hemagglutinin 5 (H5) - Drugs in Development, 2021

US$ 3,000.00

Hemagglutinin 5 (H5) - Drugs in Development, 2021 SUMMARY Hemagglutinin 5 (H5) - Drugs in Development, 2021 provides in depth analysis on Hemagglutinin 5 (H5) targeted pipeline therapeutics. The repor...

April 2021 30 pages

Hematological Disorders (Hematological Disorders) - Drugs in Development, 2021

US$ 2,000.00

Hematological Disorders (Hematological Disorders) - Drugs in Development, 2021 SUMMARY Hematological Disorders (Hematological Disorders) - Drugs in Development, 2021 provides an overview of the Hemato...

April 2021 75 pages

Hematological Tumor (Oncology) - Drugs in Development, 2021

US$ 2,500.00

Hematological Tumor (Oncology) - Drugs in Development, 2021 SUMMARY Hematological Tumor (Oncology) - Drugs in Development, 2021 provides an overview of the Hematological Tumor pipeline landscape. The...

April 2021 425 pages

Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021 SUMMARY Hematopoietic Stem Cell Transplantation (Immunology) - Drugs in Development, 2021 provides an overview of the...

April 2021 60 pages

Filters

Clear all